Clinical Trial: Corneal Thinning During Topical Bevacizumab Therapy
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title:
Brief Summary: The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
Detailed Summary:
Sponsor: Yonsei University
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Yonsei University
Dates:
Date Received: August 13, 2007
Date Started: May 2007
Date Completion:
Last Updated: April 29, 2015
Last Verified: April 2015